Bank Pictet & Cie (Europe) AG
Source: SEC Form 13F · as of Mar 2026Bank Pictet & Cie (Europe) AG holds 19 biotech & pharma companies tracked by BioSniper, totaling $414.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$414.3M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 405,604 | $88.2M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 200,181 | $54.2M |
| PMPhilip Morris International Inc | 315,469 | $52.2M |
| IDXXIDEXX LABORATORIES INC /DE | 89,000 | $50.0M |
| LLYELI LILLY & Co | 51,640 | $47.5M |
| ZTSZoetis Inc. | 358,560 | $42.4M |
| MRKMerck & Co., Inc. | 237,773 | $28.6M |
| GILDGILEAD SCIENCES, INC. | 142,229 | $19.8M |
| MRNAModerna, Inc. | 168,606 | $8.6M |
| PFEPFIZER INC | 303,202 | $8.5M |
| ABTABBOTT LABORATORIES | 48,264 | $5.0M |
| AZNASTRAZENECA PLC | 20,056 | $3.9M |
| JNJJOHNSON & JOHNSON | 8,533 | $2.1M |
| RPRXRoyalty Pharma plc | 25,000 | $1.2M |
| BMYBRISTOL MYERS SQUIBB CO | 12,000 | $728K |
| BIIBBIOGEN INC. | 2,880 | $528K |
| ELVElevance Health Inc. | 1,453 | $425K |
| QGENQIAGEN N.V. | 8,960 | $359K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 522 | $233K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.